publication venue for
- Plasma amyloid-β as a predictor of dementia and cognitive decline: a systematic review and meta-analysis.. 69:824-31. 2012
- Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study.. 69:594-600. 2012
- Amyloid-dependent and amyloid-independent stages of Alzheimer disease.. 68:1062-4. 2011
- The Structured Interview & Scoring Tool-Massachusetts Alzheimer's Disease Research Center (SIST-M): development, reliability, and cross-sectional validation of a brief structured clinical dementia rating interview.. 68:343-50. 2011
- Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative.. 67:1370-8. 2010
- Ten-year change in plasma amyloid beta levels and late-life cognitive decline.. 66:1247-53. 2009
- Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study.. 65:642-9. 2008
- Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study.. 63:1551-5. 2006
- Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study.. 63:246-50. 2006
- Bone mineral density and the risk of Alzheimer disease.. 62:107-11. 2005
- Absence of an apolipoprotein E epsilon4 allele is associated with increased parietal regional cerebral blood flow asymmetry in Alzheimer disease.. 55:1460-6. 1998
- The relationship of neuropsychological functioning to quality of life in epilepsy.. 52:997-1003. 1995